[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.7314/APJCP.2014.15.10.4261

Comparison of Psychotropic Prescriptions between Oncology and Cardiology Inpatients: Result from a Pharmacy Database in a Teaching Hospital in Malaysia

Ng, Chong Guan (Department of Psychological Medicine, University Malaya Medical Centre)
Mohamed, Salina (Department of Psychiatry, Faculty of Medicine, Universiti Teknologi MARA)
Wern, Tai Yi (Department of Pharmacy, University Malaya Medical Centre)
Haris, Azwa (Department of Pharmacy, University Malaya Medical Centre)
Zainal, Nor Zuraida (Department of Psychological Medicine, University Malaya Medical Centre)
Sulaim, Ahmad Hatim (Department of Psychological Medicine, University Malaya Medical Centre)

Publication Information

Asian Pacific Journal of Cancer Prevention / v.15, no.10, 2014 , pp. 4261-4264 More about this Journal

Abstract

Objective: To examine the prescription rates in cancer patients of three common psychotropic drugs: anxiolytic/hypnotic, antidepressant and antipsychotic. Materials and Methods: In this retrospective cohort study, data were extracted from the pharmacy database of University Malaya Medical Center (UMMC) responsible for dispensing records of patients stored in the pharmacy's Medication Management and Use System (Ascribe). We analyzed the use of psychotropics in patients from the oncology ward and cardiology from 2008 to 2012. Odds ratios (ORs) were adjusted for age, gender and ethnicity. Results: A total of 3,345 oncology patients and 8,980 cardiology patients were included. Oncology patients were significantly more often prescribed psychotropic drugs (adjusted OR: anxiolytic/hypnotic=5.55 (CI: 4.64-6.63); antidepressants=6.08 (CI: 4.83-7.64) and antipsychotics=5.41 (CI: 4.17-7.02). Non-Malay female cancer patients were at significantly higher risk of anxiolytic/hypnotic use. Conclusions: Psychotropic drugs prescription is common in cancer patients. Anxiolytic/hypnotic prescription rates are significantly higher in non-Malay female patients in Malaysia.

Keywords

Prescription; psychotropic; oncology; cardiology; Malaysia;

Citations & Related Records

Times Cited By KSCI : 4 (Citation Analysis)

Reference
Cited By KSCI

1	Shaharudin SH, Sulaiman S, Emran NA, Shahril MR, Syed Hussain SNA (2011). The use of complementary and alternative medicine among Malay breast cancer survivors. Altern Ther Health Med, 17, 50-6.
2	Grassi L, Caruso R, Hammelef K, Nanni MG, Riba M (2014). Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry, 26, 44-62. DOI ScienceOn
3	Derogatis LR, Feldstein M, Morrow G, et al (1979). A survey of psychotropic drug prescriptions in an oncology population. Cancer, 44, 1919-29. DOI
4	Goldberg RJ, Mor V (1985). A survey of psychotropic use in terminal cancer patients. Psychosomatics, 26, 745-51. DOI ScienceOn
5	Grabsch B, Clarke DM, Love A, et al (2006). Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care, 4, 47-56.
6	Hopwood P, Howell A, Maguire P (1991). Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer, 64, 349-52. DOI ScienceOn
7	Khan NF, Ward AM, Watson E, et al (2010). Consulting and prescribing behaviour for anxiety and depression in longterm survivors of cancer in the UK. Eur J Cancer, 46, 3339-44. DOI ScienceOn
8	King M, Llewellyn H, Leurent B, et al (2013). Spiritual beliefs near the end of life: a prospective cohort study of people with cancer receiving palliative care. Psychooncology, 22, 2505-12. DOI ScienceOn
9	Stromgren AS, Goldschmidht D, Groenvold M, et al (2002). Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer, 94, 512-20. DOI ScienceOn
10	Wilson KG, Chochinov HM, Skirko MG, et al (2007). Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage, 33, 118-29. DOI ScienceOn
11	Yong CK, Young HY, Ki HL, et al (2006). Symptoms in the lives of terminal cancer patients: which is the most important? Oncology, 71, 69-76. DOI ScienceOn
12	Zainal NZ, Nik-Jaafar NR, Baharudin A, Ahmad Sabki Z, Ng CG (2013). Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pac J Cancer Prev, 14, 2649-56. 과학기술학회마을 DOI ScienceOn
13	Butler LD, Koop C, Classen C, Spiegel D (1999). Traumatic stress, life events, and emotional support in women with metastatic breast cancer: cancer-related traumatic stress symptoms associated with past and current stressors. Health Psychol, 18, 555-60. DOI ScienceOn
14	Liu DG, Wang SS, Peng RJ, et al (2011). Interaction of social support and psychological stress on anxiety and depressive symptoms in breast cancer Patients. Asian Pac J Cancer Prev, 12, 2523-9.
15	Maneeton B, Maneeton N, Mahathep P (2012). Prevalence of depression and its correlations: a cross-sectional study in Thai cancer patients. Asian Pac J Cancer Prev, 13, 2039-43. 과학기술학회마을 DOI ScienceOn
16	Adler NE, Page AEK, eds. (2007). Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: National Academies Press.
17	Caruso R, Grassi L, Nanni MG, Riba M (2013). Psychopharmacology in psycho-oncology. Curr Psychiatry Rep, 15, 393. DOI ScienceOn
18	Cullivan, Crown, Walsh (1998). The use of psychotropic medication in patients referred to a psycho-oncology service. Psychooncology, 7, 301-6. DOI
19	Dastan NB, Buzlu S (2011). Depression and anxiety levels in early stage Turkish breast cancer patients and related factors. Asian Pac J Cancer Prev, 12, 137-41.
20	Merriam S, Muhamad M (2013). Roles traditional healers play in cancer treatment in Malaysia: implications for health promotion and education. Asian Pac J Cancer Prev, 14, 3593-601. 과학기술학회마을 DOI ScienceOn
21	Miovic M, Block S (2007). Psychiatric disorders in advanced cancer. Cancer, 110, 1665-76. DOI ScienceOn
22	Muriel AC, Hwang VS, Kornblith A, et al (2009). Management of psychosocial distress by oncologists. Psychiatric Services, 60, 1132-4. DOI
23	Muzzin LJ, Anderson NJ, Figueredo AT, Gudelis SO (1994). The experience of cancer. Soc Sci Med, 38, 1201-8. DOI ScienceOn
24	Ng CG, Dijkstra E, Smeets H, Boks MP, de Wit NJ (2013). Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure. Br J Gen Pract, 63, 63-8. DOI
25	Peterson LG, Leipman M, Bongar B (1987). Psychotropic medications in patients with cancer. Gen Hosp Psychiat, 9, 313-23. DOI ScienceOn
26	Ross DD, Alexender CS (2001). Management of common symptoms in terminally ill patients. I. Fatigue, anorexia, cachexia, nausea and vomitting. Am Fam Physician, 64, 807-14.
27	Sahin ZA, Tan M, Polat H (2013). Hopelessness, depression and social support with end of life Turkish Cancer Patients. Asian Pac J Cancer Prev, 14, 2823-8. 과학기술학회마을 DOI ScienceOn
28	Ng CG, Boks MP, Smeets HM, Zainal NZ, de Wit NJ (2013a). Prescription patterns for psychotropic drugs in cancer patients: a large population study in the Netherlands. Psychooncology, 22, 762-7. DOI ScienceOn

11	Cécile Conte. (2016) Supportive Care in Cancer Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin’s lymphoma: a cohort study of the French national health insurance database / 24 (11) , 4791
9	Saira Sanjida. (2016) Psycho-Oncology A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients / 25 (9) , 1002
2	Guan Chong Ng. (2017) Journal of Religion and Health Anxiety and Depression in Cancer Patients: The Association with Religiosity and Religious Coping / 56 (2) , 575
1433-7339	(2017) Supportive Care in Cancer What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital / (1433-7339)
1	(2018) BMC Complementary and Alternative Medicine Does Jacobson’s relaxation technique reduce consumption of psychotropic and analgesic drugs in cancer patients? A multicenter pre–post intervention study / 18 (1)